Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Feb 9, 2012 · 10-K · 40 days after period end · 0001193125-12-049361
| Metric | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|
| Revenue | $2.75M | — |
| Net Income | -$391.00K | — |
| EPS Diluted | -$0.01 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Dec 31, 2011 · filed Feb 9, 2012 · 40 d after period end
